CHPA Responds to Sen. Schumer’s Call for Mandatory Flow Restrictors on Children’s Liquid Medicines

Tue, 01/21/2014 - 8:23am

The Consumer Healthcare Products Association issued a statement in response to Sen. Charles Schumer’s (D-N.Y.) call for the U.S. Food and Drug Administration and the Consumer Product Safety Commission to require flow restrictors on all bottles of children's liquid medicines:

“CHPA and its member companies share a goal of ensuring that parents and caregivers have access to the best medicines possible as well as resources to use them safely, appropriately, and in a cost-effective manner.

“We are involved in a number of long-term efforts targeted at preventing accidental, unsupervised ingestion of medicines by young children. The most impactful solution is locking the child-resistant closure and storing all medicines up and away and out of children's reach. This is why we educate parents and caregivers to store medicines up and away and out of sight through a campaign led by CHPA’s Educational Foundation and the U.S. Centers for Disease Control’s PROTECT Initiative.

“The manufacturers have voluntarily added flow restrictors to infants’ and children’s liquid acetaminophen products. Flow restrictors are one tool for parents that industry employs to reduce the amount of medicine a child who defeats the child-resistant packaging might ingest. Because medicines are meant to be accessible, flow restrictors aren’t sufficient to prevent accidental, unsupervised medicine ingestions, but safe and appropriate storage is.

“While there is currently no regulating authority over flow restrictors, child-resistant packaging is regulated by U.S. Food and Drug Administration and Consumer Product Safety Commission. We continue to study and advance child-resistant packaging technologies."


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.